51865-32-8,MFCD20482282
Catalog No.:AA01DHX1

51865-32-8 | 3-bromocyclopent-2-en-1-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
93%
in stock  
$271.00   $190.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01DHX1
Chemical Name:
3-bromocyclopent-2-en-1-one
CAS Number:
51865-32-8
Molecular Formula:
C5H5BrO
Molecular Weight:
160.9966
MDL Number:
MFCD20482282
SMILES:
BrC1=CC(=O)CC1
Properties
Properties
 
Form:
Solid  
Storage:
-20 ℃;Light sensitive;  


Downstream Synthesis Route

[1]Marson;Farrand;Brettle;Dunmur[Tetrahedron,2003,vol.59,#24,p.4377-4381]

[2]CurrentPatentAssignee:CHARLESRIVERLABORATORIESINTERNATIONALINC;NIMBUSTHERAPEUTICSINC;NIMBUSSATURN-US2021/78996,2021,A1Locationinpatent:Paragraph0979;0980

[3]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1Locationinpatent:Page/Pagecolumn55

[4]Lin,Hsin-Hui;Chiang,Tai-Ching;Wu,Rong-Xuan;Chang,Yi-Mei;Wang,Hao-Wen;Liu,Ssu-Ting;Yeh,Ming-ChangP.[AdvancedSynthesisandCatalysis,2019]

[5]Kremsmair,Alexander;Skotnitzki,Juri;Knochel,Paul[Chemistry-AEuropeanJournal,2020,vol.26,#52,p.11971-11973]

[6]Piers,Edward;Grierson,JohnR.;Lau,CheukKun;Nagakura,Isao[CanadianJournalofChemistry,1982,vol.60,p.210-223]

[7]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-US2019/185469,2019,A1Locationinpatent:Paragraph0562-0563

[8]Shih,Chuan;Swenton,JohnS.[JournalofOrganicChemistry,1982,vol.47,#15,p.2825-2832]

[9]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1Locationinpatent:Page/Pagecolumn218

[10]Vogensen,StineB.;Marek,Aleš;Bay,Tina;Wellendorph,Petrine;Kehler,Jan;Bundgaard,Christoffer;Frølund,Bente;Pedersen,MartinH.F.;Clausen,RasmusP.[JournalofMedicinalChemistry,2013,vol.56,#20,p.8201-8205]

[11]Khader,K.K.Abdul;Sajith,AyyiliathM.;Padusha,M.SyedAli;Nagaswarupa;Muralidharan[NewJournalofChemistry,2014,vol.38,#3,p.1294-1305]

[12]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US9242996,2016,B2Locationinpatent:Page/Pagecolumn93;94

[13]CurrentPatentAssignee:MERCK&COINC-WO2016/122994,2016,A1Locationinpatent:Page/Pagecolumn47;48

[14]Jensen,ClausH.;Hansen,HanneD.;Bay,Tina;Vogensen,StineB.;Lehel,Szabolcs;Thiesen,Louise;Bundgaard,Christoffer;Clausen,RasmusP.;Knudsen,GitteM.;Herth,MatthiasM.;Wellendorph,Petrine;Frølund,Bente[ACSChemicalNeuroscience,2017,vol.8,#1,p.22-27]

[15]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2018/53157,2018,A1Locationinpatent:Page/Pagecolumn77

[16]Wang,Qi;Zhang,Chao;Yang,Jun[ChineseChemicalLetters,2020,vol.31,#7,p.1906-1910]

[17]Griem-Krey,Nane;Frølund,Bente;Marek,Aleš;Wellendorph,Petrine[Journaloflabelledcompoundsandradiopharmaceuticals,2021,vol.64,#2,p.77-81]

[1]CurrentPatentAssignee:NIMBUSTHERAPEUTICSINC;CHARLESRIVERLABORATORIESINTERNATIONALINC;NIMBUSSATURN-US2021/78996,2021,A1Locationinpatent:Paragraph0979;0981

[2]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-US2019/185469,2019,A1Locationinpatent:Paragraph0564-0565

[3]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1Locationinpatent:Page/Pagecolumn55

[4]CurrentPatentAssignee:TETRADISCOVERYPARTNERS-WO2014/66659,2014,A1Locationinpatent:Paragraph0732

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1Locationinpatent:Page/Pagecolumn218-219

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US9242996,2016,B2Locationinpatent:Page/Pagecolumn93;94;95

[7]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2018/53157,2018,A1Locationinpatent:Page/Pagecolumn77;78

[1]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2020/86533,2020,A1Locationinpatent:Page/Pagecolumn98

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 51865-32-8
Building Blocks
More >
Tags:51865-32-8 Molecular Formula|51865-32-8 MDL|51865-32-8 SMILES|51865-32-8 3-bromocyclopent-2-en-1-one
Catalog No.: AA01DHX1
51865-32-8,MFCD20482282
51865-32-8 | 3-bromocyclopent-2-en-1-one
Pack Size: 250mg
Purity: 93%
in stock
$271.00 $190.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01DHX1
Chemical Name: 3-bromocyclopent-2-en-1-one
CAS Number: 51865-32-8
Molecular Formula: C5H5BrO
Molecular Weight: 160.9966
MDL Number: MFCD20482282
SMILES: BrC1=CC(=O)CC1
Properties
Form: Solid  
Storage: -20 ℃;Light sensitive;  
Downstream Synthesis Route
3859-41-4    51865-32-8 

[1]Marson;Farrand;Brettle;Dunmur[Tetrahedron,2003,vol.59,#24,p.4377-4381]

[2]CurrentPatentAssignee:CHARLESRIVERLABORATORIESINTERNATIONALINC;NIMBUSTHERAPEUTICSINC;NIMBUSSATURN-US2021/78996,2021,A1Locationinpatent:Paragraph0979;0980

[3]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1Locationinpatent:Page/Pagecolumn55

[4]Lin,Hsin-Hui;Chiang,Tai-Ching;Wu,Rong-Xuan;Chang,Yi-Mei;Wang,Hao-Wen;Liu,Ssu-Ting;Yeh,Ming-ChangP.[AdvancedSynthesisandCatalysis,2019]

[5]Kremsmair,Alexander;Skotnitzki,Juri;Knochel,Paul[Chemistry-AEuropeanJournal,2020,vol.26,#52,p.11971-11973]

[6]Piers,Edward;Grierson,JohnR.;Lau,CheukKun;Nagakura,Isao[CanadianJournalofChemistry,1982,vol.60,p.210-223]

[7]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-US2019/185469,2019,A1Locationinpatent:Paragraph0562-0563

[8]Shih,Chuan;Swenton,JohnS.[JournalofOrganicChemistry,1982,vol.47,#15,p.2825-2832]

[9]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1Locationinpatent:Page/Pagecolumn218

[10]Vogensen,StineB.;Marek,Aleš;Bay,Tina;Wellendorph,Petrine;Kehler,Jan;Bundgaard,Christoffer;Frølund,Bente;Pedersen,MartinH.F.;Clausen,RasmusP.[JournalofMedicinalChemistry,2013,vol.56,#20,p.8201-8205]

[11]Khader,K.K.Abdul;Sajith,AyyiliathM.;Padusha,M.SyedAli;Nagaswarupa;Muralidharan[NewJournalofChemistry,2014,vol.38,#3,p.1294-1305]

[12]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US9242996,2016,B2Locationinpatent:Page/Pagecolumn93;94

[13]CurrentPatentAssignee:MERCK&COINC-WO2016/122994,2016,A1Locationinpatent:Page/Pagecolumn47;48

[14]Jensen,ClausH.;Hansen,HanneD.;Bay,Tina;Vogensen,StineB.;Lehel,Szabolcs;Thiesen,Louise;Bundgaard,Christoffer;Clausen,RasmusP.;Knudsen,GitteM.;Herth,MatthiasM.;Wellendorph,Petrine;Frølund,Bente[ACSChemicalNeuroscience,2017,vol.8,#1,p.22-27]

[15]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2018/53157,2018,A1Locationinpatent:Page/Pagecolumn77

[16]Wang,Qi;Zhang,Chao;Yang,Jun[ChineseChemicalLetters,2020,vol.31,#7,p.1906-1910]

[17]Griem-Krey,Nane;Frølund,Bente;Marek,Aleš;Wellendorph,Petrine[Journaloflabelledcompoundsandradiopharmaceuticals,2021,vol.64,#2,p.77-81]

51865-32-8    73183-34-3    1370008-65-3 

[1]CurrentPatentAssignee:NIMBUSTHERAPEUTICSINC;CHARLESRIVERLABORATORIESINTERNATIONALINC;NIMBUSSATURN-US2021/78996,2021,A1Locationinpatent:Paragraph0979;0981

[2]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-US2019/185469,2019,A1Locationinpatent:Paragraph0564-0565

[3]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1Locationinpatent:Page/Pagecolumn55

[4]CurrentPatentAssignee:TETRADISCOVERYPARTNERS-WO2014/66659,2014,A1Locationinpatent:Paragraph0732

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1Locationinpatent:Page/Pagecolumn218-219

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US9242996,2016,B2Locationinpatent:Page/Pagecolumn93;94;95

[7]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2018/53157,2018,A1Locationinpatent:Page/Pagecolumn77;78

1246765-32-1    51865-32-8    2417112-63-9 

[1]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2020/86533,2020,A1Locationinpatent:Page/Pagecolumn98

Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.